Correction to: Early clinical response to tofacitinib treatment as a predictor of subsequent efficacy: Results from two phase 3 studies of patients with moderate-to-severe plaque psoriasis.

Correction to: Early clinical response to tofacitinib treatment as a predictor of subsequent efficacy: Results from two phase 3 studies of patients with moderate-to-severe plaque psoriasis.
J Dermatolog Treat. 2017 Feb;28(1):x
Authors:
PMID: 28201942 [PubMed - in process]

Source: Journal of Dermatological Treatment - February 22, 2017 Category: Dermatology Tags: J Dermatolog Treat Source Type: research